Related by context. All words. (Click for frequent words.) 77 Panzem R 76 Archexin 76 2 methoxyestradiol 76 oral prodrug 75 generation purine nucleoside 75 Aflibercept 75 MAGE A3 ASCI 75 OvaRex R 75 Allovectin 7 75 targeted radiotherapeutic 75 Panzem NCD 75 forodesine 75 Bezielle 75 TBC# 75 HGS ETR1 74 SinuNase TM 74 Chemophase 74 Cloretazine ® 74 alvespimycin 74 Xanafide 74 orally administered inhibitor 74 galiximab 74 refractory chronic lymphocytic 74 PI3K/Akt pathway inhibitor 74 paclitaxel Taxol ® 74 acyclovir Lauriad R 74 volociximab 74 metaglidasen 73 PDE4 inhibitor 73 Solazed 73 PDX pralatrexate 73 receptor tyrosine kinase inhibitor 73 liposomal formulation 73 ELACYT 73 docetaxel Taxotere R 73 tubulin inhibitor 73 FUSILEV enhances 73 YONDELIS 73 HGS ETR2 73 cilengitide 73 AEG# 73 AzaSite Plus 73 PEG SN# 73 AQ4N 73 HGS# 73 Phase Ib II 73 FOLOTYN ® 73 Tarceva TM 73 novel VDA molecule 73 SinuNase ™ 73 Phase #b/#a clinical 73 vinorelbine tartrate 73 AAG geldanamycin analog 73 Alocrest 73 bevacizumab Avastin ® 73 HuMax CD4 73 deforolimus 73 FOLFOX6 chemotherapy regimen 72 lintuzumab SGN 72 evaluating tivozanib 72 CYT# potent vascular disrupting 72 radiation sensitizer 72 TELINTRA 72 mertansine 72 HCD# [002] 72 HuMax EGFr 72 incyclinide 72 ixabepilone 72 SPRYCEL ® 72 erlotinib Tarceva ® 72 Personalized Immunotherapy 72 PSMA ADC 72 trastuzumab Herceptin R 72 sunitinib malate 72 lapatinib Tykerb 72 docetaxel Taxotere ® 72 Pivotal Phase III 72 Allovectin 7 ® 72 cediranib 72 Omacetaxine 72 oral picoplatin 72 elotuzumab 72 Xeloda ® 72 eniluracil 72 oral ridaforolimus 72 thalidomide Thalomid 72 Traficet EN 72 epothilone 72 Annamycin 72 REOLYSIN ® 72 including eniluracil ADH 72 XL# XL# 72 Exelixis compounds 72 Allovectin 7 R 72 ularitide 72 MyVax R 72 gemcitabine Gemzar 72 Solazed TM 72 R sorafenib tablets 72 PNP inhibitor 72 investigational monoclonal antibody 72 MEK inhibitors 72 Clolar ® 72 dasatinib Sprycel 72 Elotuzumab 72 Meets Primary Endpoint 72 neratinib 72 GW# [003] 72 Glufosfamide 72 torezolid phosphate 72 evaluating picoplatin 72 HSP# inhibitor 72 Phase IIb clinical trials 72 ospemifene 72 Initiate Clinical Trial 72 Cloretazine 71 OMP #M# 71 Trofex 71 Proxinium TM 71 antibody MAb 71 sorafenib tablets 71 Darinaparsin 71 IMC A# 71 ganetespib 71 PANVAC VF 71 HuLuc# 71 subcutaneous formulation 71 immunotherapeutic agent 71 ZEVALIN ® 71 Inhalation Solution 71 dasatinib Sprycel ® 71 INCB# [001] 71 CR# vcMMAE 71 Daclizumab 71 Pemetrexed 71 MGd 71 pertuzumab 71 L BLP# 71 OncoVEX GM CSF 71 XL# XL# XL# XL# 71 Fludara ® 71 cetuximab Erbitux R 71 XL# anticancer compounds 71 KRN# 71 Preclinical studies suggest 71 Initiates Enrollment 71 IL# PE#QQR 71 gemcitabine Gemzar ® 71 nucleoside analog 71 small molecule Hedgehog 71 alkylating agent 71 TLK# 71 Aplidin 71 Romidepsin 71 vidofludimus 71 Ixabepilone 71 farletuzumab 71 IMA# 71 oral proteasome inhibitor 71 5 fluorouracil leucovorin 71 JAK inhibitor 71 Sapacitabine 71 pan HDAC inhibitor 71 Cloretazine R VNP#M 71 Onconase 71 RhuDex ® 71 mapatumumab 71 alefacept 71 Peginterferon alfa 2b 71 CD# CEA 71 interferon gamma 1b 71 CTAP# Capsules 71 immunomodulatory therapy 71 vascular disrupting agents 71 IAP inhibitors 71 recurrent metastatic ovarian cancer 71 GVAX ® 71 Gemzar ® 71 Triapine R 71 Abiraterone acetate 71 pegylated interferons 71 XYOTAX TM 71 multitargeted 71 5 FU leucovorin 71 paclitaxel poliglumex 71 TOCOSOL Camptothecin 71 OvaRex ® MAb 71 HCV protease inhibitors 71 Quinamed 71 LEP ETU 71 docetaxel Taxotere 71 pharmacologically active isomer 71 novel emulsion formulation 71 Temsirolimus 71 DAVANAT 71 TELINTRA R 71 Targretin capsules 71 PF # [002] 71 Sanofi Aventis Taxotere 71 Elagolix 71 epigenetic therapies 71 Bortezomib 71 atacicept 71 LibiGel ® 71 Trastuzumab DM1 71 oral talactoferrin 71 Orally administered 71 vinca alkaloid 70 Plicera 70 Pimavanserin 70 Xcytrin R 70 tezampanel 70 Pralatrexate 70 RH1 70 evaluating satraplatin 70 alpha 2a 70 IRX 2 70 Taxotere chemotherapy 70 BENLYSTA ® 70 Squalamine 70 PRT# 70 small molecule chemotherapeutic 70 Androxal TM 70 KSP inhibitor 70 MKC# MT 70 relapsed MM 70 Hsp# Inhibitor 70 oral antiviral 70 CEQ# 70 aflibercept 70 Factor VIIa 70 hypoxia activated prodrug 70 DOS# 70 Vidaza azacitidine 70 HGS ETR1 mapatumumab 70 #ME# 70 Amrubicin 70 Nanobody 70 LymphoStat B TM 70 ZOLINZA 70 PrevOnco ™ 70 MGCD# [001] 70 demonstrated antitumor activity 70 AKT inhibitor 70 histamine dihydrochloride 70 gefitinib Iressa 70 candidate deforolimus 70 VNP#M 70 phase IIb clinical 70 GRNVAC1 70 BrachySil TM 70 Capesaris 70 Pertuzumab 70 Telintra 70 adecatumumab 70 RhuDex TM 70 Apoptone 70 Xelox 70 romidepsin 70 IAP inhibitor 70 alfa 2a 70 Myocet 70 Copegus ribavirin 70 oral rivaroxaban 70 cisplatin gemcitabine 70 LEUKINE 70 DEB# 70 OMP #R# 70 NeuroSTAT ® 70 Mipomersen 70 Azedra TM 70 SAR# [004] 70 Vaxfectin TM 70 EOquin TM 70 Targretin 70 PEGylated interferon 70 TOCOSOL Paclitaxel 70 bortezomib Velcade 70 celgosivir 70 sorafenib Nexavar 70 Voreloxin 70 selective modulator 70 PEGylated Fab fragment 70 aflibercept VEGF Trap 70 Phase #b/#a 70 oxymorphone ER 70 isoform selective 70 Amplimexon 70 successfully commercialize Iluvien 70 Evoltra ® 70 goserelin 70 Rebif ® 70 trastuzumab DM1 T DM1 70 Ophena TM 70 vosaroxin 70 pharmacokinetic PK study 70 Platinol ® cisplatin 70 HuMax TAC 70 topical ophthalmic 70 proteasome inhibitor 70 Neuradiab 70 BrachySil 70 Androxal ® 70 PEG interferon 70 JAK1 70 Immunotherapeutic 70 Azedra 70 GMX# 70 TG# [003] 70 LymphoStat B belimumab 70 maximally tolerated dose 70 indibulin 70 Bayer HealthCare Onyx Pharmaceuticals 70 histone deacetylase HDAC inhibitor 70 Luteinizing Hormone Releasing Hormone 70 acetonide FA 70 selective kinase inhibitor 70 targeted antifolate 70 Deforolimus 70 Phase Ib study 70 SILENOR 70 IMiDs ® 70 MNTX 70 Alfacell proprietary ribonuclease 70 lymphoid malignancies 70 Exherin 70 EndoTAGTM 1 70 Pharmacokinetics PK 70 Interferon beta 1a 70 Vicinium TM 70 pain palliation 70 SERMs 70 investigational humanized monoclonal antibody 70 adenosine injection 70 Vidaza R 70 Pazopanib 70 Phase #b/#a trial 70 cisplatin carboplatin 70 FOLFOX6 70 Neulasta ® 70 nalbuphine ER 70 velafermin 70 THR beta agonist 70 enzastaurin 70 Marqibo TM 69 SUTENT ® 69 urocortin 2 69 PLK1 SNALP 69 JAK2 inhibitor 69 IMC #B 69 Vitaxin 69 NXL# 69 pomalidomide 69 Tesetaxel 69 tezampanel NGX# 69 G#DT 69 ibritumomab tiuxetan 69 novel histone deacetylase 69 non nucleoside inhibitor 69 docetaxel chemotherapy 69 Kamada AAT 69 uric acid lowering 69 sargramostim 69 Vidaza ® 69 CBLC# 69 intranasal formulation 69 CCR5 antagonist 69 Civacir 69 sunitinib Sutent 69 MAXY alpha 69 mitomycin 69 gemcitabine cisplatin 69 catheter occlusion 69 ONCONASE R 69 Pruvel 69 potent antiproliferative 69 preclinically 69 bortezomib Velcade R 69 Dalbavancin 69 herpetic keratitis 69 TKM ApoB 69 Phase 2b Clinical Trial 69 octreotide acetate 69 oncolytic virus therapies 69 Pegylated Interferon 69 Completes Patient Enrollment 69 ENMD # 69 Irinotecan 69 initiated Phase Ib 69 triphendiol 69 CA4P 69 paclitaxel Taxol 69 phase Ib 69 depsipeptide 69 Tekamlo 69 Tyrima 69 Triapine 69 Pegloticase 69 dextromethorphan quinidine 69 ATL# [002] 69 AMPK activators 69 Phase Ib clinical trials 69 pharmacodynamic properties 69 OHR/AVR# 69 topical antifungal 69 nucleoside reverse transcriptase inhibitor 69 AMEVIVE 69 carboplatin paclitaxel 69 cancer immunotherapies 69 Nexavar ® 69 bendamustine 69 Crofelemer budesonide foam 69 GLP toxicology studies 69 metastatic hormone refractory 69 vapreotide acetate 69 sapacitabine 69 TACI Ig 69 ZK EPO 69 HER2 positive metastatic breast 69 administered subcutaneously 69 Panzem ® 69 selective androgen receptor modulator 69 evaluating Xcytrin 69 Carfilzomib 69 otelixizumab 69 sorafenib Nexavar ® 69 phase IIa clinical 69 R#/MEM # 69 TKB# 69 ® bortezomib 69 TRAIL receptor antibodies 69 oral taxane 69 Adenoscan R 69 rxRNA 69 Multiple Ascending Dose 69 Ecallantide 69 UPLYSO 69 selective estrogen receptor modulator 69 progressive metastatic prostate 69 EOquin 69 IMiDs R 69 Vinorelbine 69 MCSP respectively 69 EFAPROXYN 69 XmAb# 69 ongoing Phase 1b 69 CG# [003] 69 BAY #-# 69 RIGScan CR 69 Dacogen injection 69 Fodosine 69 telaprevir VX 69 Canvaxin TM 69 Fulvestrant 69 ONTAK 69 TAFA# 69 NPC 1C 69 ceftazidime 69 PORxin TM 69 cannabinor 69 selective A2A adenosine receptor 69 Exherin TM 69 systemically administered 69 IgG1 monoclonal antibody 69 Leukine ® 69 Genasense ® oblimersen 69 huC# DM4 69 fosbretabulin 69 Iloperidone 69 TRO# 69 Perifosine 69 pegylated liposomal doxorubicin 69 Thalomid ® 69 lintuzumab 69 trastuzumab DM1 69 selective orally bioavailable 69 IV Busulfex 69 CoFactor 69 multi kinase inhibitor 69 Maximum Tolerated Dose MTD 69 entinostat 69 Guanilib 69 capecitabine Xeloda 69 seliciclib CYC# 69 Degarelix 69 vorinostat 69 low dose cytarabine 69 personalized immunotherapy 69 thymalfasin 69 PXD# 69 plus prednisone prednisolone 69 anticancer compound 69 Intravenous CP 69 generation Hsp# inhibitor 69 obatoclax 69 lenalidomide Revlimid R 69 BRIM2 69 Onco TCS 69 Presents Preclinical Data 69 CA9 SCAN 69 Pegylated 69 Seliciclib 69 Hectorol R 69 ADP receptor antagonist 69 Insegia 69 XP# XP# 69 Shigamabs ® 69 orally disintegrating 69 TRISENOX 69 Telatinib 69 Dasatinib 69 Symadex 69 virus HCV protease inhibitor 69 Laquinimod 69 VEGFR2 inhibitor 69 bevacizumab Avastin R 69 Simulect 69 topical gel formulation 68 Proellex TM 68 ALN PCS 68 orBec 68 anti CD# antibodies 68 estramustine 68 HDAC Inhibitor 68 sitaxsentan 68 Zemiva TM 68 Zybrestat 68 liposomal doxorubicin 68 5 HT3 antagonist 68 adipiplon 68 registrational trial 68 Proquin XR 68 Gemzar gemcitabine 68 EGS# 68 kidney urologic 68 Alzhemed TM 68 evaluating Actimmune 68 Dapagliflozin 68 Anidulafungin 68 MAXY G# 68 Successfully Completes Phase 68 Aganocide 68 octreotide implant 68 Initiates Clinical 68 Aplidin R 68 JAK2 Inhibitor 68 vaccines oncolytic virus 68 Sudhir Agrawal D.Phil 68 therapeutic monoclonal antibody 68 cancer neuroendocrine tumor 68 Pyridorin 68 rituximab Rituxan 68 Asentar 68 subcutaneously administered 68 OXi# 68 oral salmon calcitonin 68 XL# XL# XL# 68 Vidofludimus 68 KNS # 68 dacetuzumab 68 #I TM# 68 Tezampanel 68 Troxatyl 68 xanthine oxidase inhibitor 68 Taxotere docetaxel 68 Anti VEGF 68 NVA# 68 ganaxolone 68 ISTODAX 68 long acting muscarinic 68 Anturol TM 68 midstage clinical 68 MOVIPREP R 68 ribavirin RBV 68 CINQUIL 68 erlotinib Tarceva R 68 antiangiogenic agents 68 oxaliplatin Eloxatin 68 visilizumab 68 EndoTAG TM -1 68 Panzem 68 tramiprosate Alzhemed TM 68 HQK 68 Epratuzumab 68 Initiates Phase III 68 cetuximab Erbitux ® 68 Phase III Clinical Trial 68 Amigal 68 NP2 Enkephalin 68 aplindore 68 CCX# 68 FUSILEV ® 68 Angiocept 68 CCR9 antagonist 68 Pafuramidine 68 Alferon N 68 5 Fluorouracil 68 Darusentan 68 boosted protease inhibitor 68 subcutaneous SC 68 DermaVir Patch 68 hyaluronidase enzyme 68 ABILIFY ® 68 sapacitabine CYC# 68 cytokine refractory 68 pegylated interferon alpha 2a 68 Campath ® 68 clevidipine 68 tumor vascular disrupting 68 SYN# 68 Interferon alpha 68 accumulate preferentially 68 Trofex TM 68 Aeroquin 68 ASONEP TM 68 irinotecan doxorubicin oxaliplatin paclitaxel 68 Cloretazine R 68 orally dosed 68 regorafenib 68 favorable pharmacokinetic profile 68 AEGR 68 Virulizin ® 68 JAK inhibitors 68 Initiates Phase II 68 lumiliximab 68 hepatitis C protease inhibitor 68 fluoropyrimidine 68 Hedgehog Pathway Inhibitor 68 Orencia abatacept 68 ruxolitinib 68 concurrent chemoradiation 68 Ixempra 68 Xcellerated T Cells 68 Pivotal Phase 68 CRMD# 68 tiapamil 68 CRLX# 68 EP #R 68 lenalidomide dexamethasone 68 LHRH antagonists 68 Camptosar ® 68 PrevOnco 68 cathepsin K inhibitor 68 Initiate Phase 68 OMNARIS HFA 68 Copegus ® 68 small molecule tyrosine 68 Ostabolin C TM 68 Pathway Inhibitor 68 Vilazodone 68 CYT# vascular disrupting 68 molecular imaging radiopharmaceutical 68 SNT MC# 68 targeting CD# 68 Glatiramer Acetate 68 omega interferon 68 relapsed multiple myeloma 68 Cloretazine VNP#M 68 Genasense ® 68 TELCYTA 68 TO AVOID PREGNANCY WHILE 68 Neulasta R 68 Aclidinium 68 Fibrillex TM 68 Ceflatonin R 68 Talabostat 68 motexafin gadolinium Injection 68 Silenor ® 68 TRX1 68 sorafenib Nexavar R 68 endothelin receptor antagonists 68 Stedivaze 68 delivers fluocinolone acetonide FA 68 Phase 1b clinical trials 68 leading oral taxane 68 chemotherapy FOLFOX 68 ® lenalidomide 68 ONCASPAR 68 DexaSite 68 reslizumab 68 Hormone Refractory Prostate Cancer 68 YONDELIS R 68 TPI ASM8 68 Campath alemtuzumab 68 Octreotide 68 Muraglitazar 68 Ophena 68 Cetuximab Erbitux 68 nab paclitaxel 68 ThermoDox R 68 BEMA TM Fentanyl 68 pegfilgrastim 68 class mGluR5 inhibitor 68 ara C 68 R#/MEM 68 GSK# [001] 68 Octreolin 68 hormone LHRH antagonist 68 taxane chemotherapy 68 fusion enhancers 68 Perforomist ™ Inhalation Solution 68 AeroLEF TM 68 Cytarabine 68 Zemplar Capsules 68 Zenvia ™ 68 GAP #B# 68 PEG IFN 68 epoetin alpha 68 thetreatment 68 abacavir lamivudine 68 miconazole Lauriad ® 68 Bicifadine 68 humanised monoclonal antibody 68 Phase IIb trials 68 blinded randomized placebo controlled 68 PROVENGE ® 68 opioid induced bowel dysfunction 68 orally inhaled migraine 68 plasma kallikrein inhibitor 68 Onalta ™ 68 Kosan dependence 68 Perforomist TM formoterol fumarate 68 anti EGFR antibody 68 Safinamide 68 BiovaxID TM 68 baminercept 68 huN# DM1 68 advanced carcinoid 67 systemic anaplastic large 67 ritonavir boosted 67 Omnitarg 67 telomerase therapeutic 67 Dual Opioid 67 MGN# 67 Mitoxantrone 67 Zorbtive TM 67 teriflunomide 67 ASONEP 67 RezularTM 67 Ceflatonin 67 orally inhaled 67 samalizumab 67 alpha 2b 67 PSN# [001] 67 beta 1a 67 personalized cellular immunotherapy 67 BRAF inhibitor 67 orally bioavailable 67 IMiDs 67 angiogenesis inhibitor 67 Zoraxel TM 67 Pegasys peginterferon alfa 2a 67 candidate CRLX# 67 overactive bladder AA# 67 Teriflunomide 67 OncoGel 67 tanespimycin 67 PEGPH# 67 Augment TM 67 decitabine 67 INTEGRILIN ® 67 IMPDH inhibitor 67 ofatumumab HuMax CD# 67 Novolimus 67 gemtuzumab ozogamicin 67 TRANSDUR Sufentanil 67 SinuNase 67 paclitaxel Taxol R 67 drug ISA# 67 polymerase inhibitor 67 MTP inhibitor 67 Cleviprex TM clevidipine 67 drug pipeline TAFA# 67 Bioral ® 67 ZACTIMA 67 Metastatic Melanoma 67 ChronVac C R 67 adecatumumab MT# 67 Pegasys ® 67 ACAPODENE TM 67 LEVADEX TM 67 ALK inhibitors 67 Kuvan R 67 CINTREDEKIN BESUDOTOX 67 DPX Survivac 67 fludarabine phosphate 67 glatiramer 67 Afatinib 67 Mycophenolate Mofetil 67 inhaled liposomal ciprofloxacin 67 melphalan prednisone 67 Phase IIb Trial 67 histone deacetylase inhibitor 67 Liposomal 67 Oxaliplatin 67 verteporfin 67 unique alkylating agent 67 PGL# 67 imatinib Gleevec ® 67 Soliris TM eculizumab 67 anti angiogenic agents 67 rNAPc2 67 candidates Azedra TM 67 Alkeran 67 systemic ALCL 67 peripherally acting 67 pentostatin 67 Navelbine ® 67 Paraplatin ® 67 CYC# 67 zileuton injection 67 Gel repository corticotropin injection 67 tenofovir emtricitabine 67 subcutaneous Herceptin 67 Theratope 67 MDS AML 67 Tykerb lapatinib 67 Fludara 67 vemurafenib 67 calcineurin inhibitors 67 idarubicin 67 CLORETAZINE TM VNP#M 67 #mg/#mg 67 relapsed leukemia 67 pralatrexate 67 Gliadel Wafer 67 TransVax ™ 67 TransVax tm 67 Canvaxin 67 glufosfamide 67 novel anticancer 67 talabostat 67 antimetabolite 67 Cardio Vascu Grow 67 IV APAP 67 modified glutathione analog 67 ANYARA 67 DCVax R 67 Onalta 67 Davanat 67 Vaprisol 67 oral deforolimus 67 Corlux 67 alemtuzumab Campath 67 custirsen 67 corticosteroid dexamethasone 67 drug conjugate 67 Silodosin 67 RAPTIVA 67 Begins Dosing 67 CHOP chemotherapy 67 Fludarabine 67 Albuferon TM 67 PRTX 67 Taxotere ® 67 Aurexis 67 investigational antiplatelet agent 67 ZYBRESTAT fosbretabulin 67 Tectin TM 67 Randomized Phase 67 GAMMAGARD 67 latrepirdine 67 Enhanze Technology 67 EGFR TKI 67 Velcade bortezomib 67 faropenem 67 relapsed ovarian cancer 67 Reports Preclinical Data 67 Aeolus Pharmaceuticals Announces 67 refractory metastatic 67 novel tubulin binding 67 ulimorelin 67 VitiGam TM 67 agonistic human 67 Cancidas 67 OvaRex 67 SUCCEED trial 67 AVONEX ® 67 TRIOLEX ™ 67 muscarinic receptor agonist 67 NEUGENE 67 adefovir dipivoxil 67 monoclonal antibody conjugated 67 Initiated Phase 67 interferon alfa 2b 67 Kahalalide F 67 infusional 67 Orapred ODT 67 investigational immunotherapy 67 Soriatane 67 polycythemia vera essential thrombocythemia 67 Eli Lilly Gemzar 67 Topotecan 67 P#X# antagonist 67 Aurora Kinase 67 PEP# [003] 67 GALNS 67 CB2 selective receptor agonist 67 Epothilones 67 busulfan 67 letrozole Femara 67 IMiDs ® compound 67 mTOR inhibitor 67 basal insulin analogue 67 HepeX B TM 67 Phase III Clinical Trials 67 NP2 67 pharmacodynamics PD 67 Pegylated interferon 67 Aurora kinase inhibitor 67 INT# [002] 67 Phase 2a Clinical Trial 67 mGluR5 NAM 67 Aptivus ® 67 calcineurin inhibitor 67 Q#IR 67 Cellegesic 67 MEK Inhibitor 67 Doxil ® 67 RGB # 67 zanolimumab 67 Azixa 67 PROSTVAC VF 67 rALLy clinical trial 67 Trastuzumab 67 marketed pegylated interferons 67 MOZOBIL 67 torezolid 67 ocular formulation 67 antiangiogenic agent 67 TMC# [002] 67 BCR ABL inhibitors 67 Actimmune ® 67 tolevamer 67 dimebon latrepirdine 67 BrachySil ™ 67 neuropathy sparing 67 assessing T DM1 67 certolizumab 67 nilotinib Tasigna 67 prokinetic agent 67 nanopharmaceutical 67 Sym# 67 induced macular edema 67 JAK2 inhibitors 67 dexamethasone Decadron 67 molecularly targeted 67 delafloxacin 67 bardoxolone 67 PSN# [002] 67 candidate TNFerade biologic 67 midstage trials 67 BZL# 67 non nucleoside 67 Neuvenge 67 TLR9 agonist 67 IIa trial 67 Zerenex 67 pegylated interferon alpha 67 Telbivudine 67 BAL# [002] 67 Ganciclovir 67 Oral NKTR 67 Cannabinor 67 DDP# 67 Teysuno 67 PegIFN 67 immune modulating 67 albiglutide 67 Urocidin 67 cMET 67 GnRH antagonist 67 Neupogen ® 67 cyclophosphamide chemotherapy 67 Interferon beta 67 EGFR HER2 67 nilotinib Tasigna ® 67 Maribavir 67 Protexia ® 67 FOLFOX chemotherapy 67 Revlimid lenalidomide 67 delta opioid receptor 67 Pfizer Camptosar 67 intravesical infusion therapy 67 Spiegelmer ® 67 Granted Orphan Drug 67 phase IIb trial 67 Granulocyte Colony Stimulating Factor 67 adalimumab Humira 67 apoptosis inducer 67 temsirolimus Torisel 67 pharmacodynamic parameters 67 Phase III Pivotal 67 Phase 2a clinical trials 67 dopamine partial agonist 67 Ozarelix 67 Telik logo TELINTRA 67 axitinib 67 ARRY #